Recent data from the COACT trial shows there may be no survival advantage when immediate coronary angiography is performed compared with delayed angiography in patients who have been successfully resuscitated after out-of-hospital cardiac arrest and who had no signs of ST-segment elevation myocardial infarction (STEMI) .
The Dutch multicentre COACT trial randomised 552 patients with cardiac arrest without signs of STEMI who were to undergo immediate coronary angiography (n=273) or delayed coronary angiography until after neurologic recovery (n=265). All participants underwent percutaneous coronary intervention if indicated. The primary endpoint of the trial was survival at 90 days; secondary endpoints included survival at 90 days with good cerebral performance or mild or moderate disability, myocardial injury, duration of catecholamine support, markers of shock, recurrence of ventricular tachycardia, duration of mechanical ventilation, major bleeding, o...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications Next Article
Convincing evidence of the role of icosapent in reducing subsequent CV events »
Table of Contents: ACC 2019
Acute and Stable Ischaemic Heart Disease
Arrhythmias and Clinical Electrophysiology
Congenital Heart Disease
Heart Failure and Cardiomyopathies
Pulmonary Arterial Hypertension and Venous Thromboembolism
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.